» Articles » PMID: 7909692

Calcein Accumulation As a Fluorometric Functional Assay of the Multidrug Transporter

Overview
Specialties Biochemistry
Biophysics
Date 1994 May 11
PMID 7909692
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Acetoxymethyl ester (AM) derivatives of various fluorescent indicators (fura-2, fluo-3, indo-1, BCECF, calcein) are actively extruded by the multidrug transporter (MDR1, P-glycoprotein-Homolya, L. et al. (1993) J. Biol. Chem. 268, 21493-21496). In the present paper we show that the measurement of the accumulation of a fluorescent cell viability marker, calcein, can be effectively used as a rapid and sensitive fluorometric and flow cytometric assay for studying P-glycoprotein function. The rate of calcein accumulation in human MDR1-expressing cells is significantly lower than in the control cells, while various drug-resistance reversing agents (verapamil, vinblastine, oligomycin, cyclosporin A and UIC2 monoclonal antibody) greatly increase calcein trapping only in the MDR1-expressing cells. Since calcein-AM is not fluorescent and free calcein is not a substrate of the multidrug transporter, the assay is readily applicable for rapid kinetic studies of the MDR1 function. Calcein has a high fluorescence intensity in the visible range, thus changes in calcein uptake can be easily visualised and MDR1-expressing and control cells separated by conventional flow cytometry.

Citing Articles

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.

Li Y, Hsiao S, Murakami M, Huang Y, Chang Y, Hung T ACS Pharmacol Transl Sci. 2024; 7(1):161-175.

PMID: 38230272 PMC: 10789147. DOI: 10.1021/acsptsci.3c00217.


Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells.

Lim Y, Kim H, Bae S, So K, Kim T, Lee J Molecules. 2024; 29(1).

PMID: 38202856 PMC: 10780346. DOI: 10.3390/molecules29010274.


Structure-based discovery of novel P-glycoprotein inhibitors targeting the nucleotide binding domains.

Moesgaard L, Pedersen M, Nielsen C, Kongsted J Sci Rep. 2023; 13(1):21217.

PMID: 38040777 PMC: 10692163. DOI: 10.1038/s41598-023-48281-4.


ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.

Ebner J, Schmoellerl J, Piontek M, Manhart G, Troester S, Carter B Nat Commun. 2023; 14(1):5709.

PMID: 37726279 PMC: 10509209. DOI: 10.1038/s41467-023-41229-2.


Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier.

Sun A, Wang J Pharm Res. 2023; 40(11):2667-2675.

PMID: 37704894 PMC: 11785364. DOI: 10.1007/s11095-023-03598-7.